Clariant AG
CLZNF
$11.53
-$0.021-0.18%
Weiss Ratings | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D+ | |||
Rating Factors | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.09 | |||
Price History | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | -0.18% | |||
60-Day Total Return | -9.65% | |||
90-Day Total Return | -21.46% | |||
Year to Date Total Return | -9.65% | |||
1-Year Total Return | -10.88% | |||
2-Year Total Return | -29.83% | |||
3-Year Total Return | -33.20% | |||
5-Year Total Return | -48.48% | |||
52-Week High % Change | -29.27% | |||
52-Week Low % Change | 0.00% | |||
Price | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $16.30 | |||
52-Week Low Price | $11.53 | |||
52-Week Low Price (Date) | Feb 12, 2025 | |||
52-Week High Price (Date) | Jul 09, 2024 | |||
Valuation | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 4.00B | |||
Enterprise Value | 5.88B | |||
Price/Earnings (TTM) | 13.81 | |||
Earnings Per Share (TTM) | 0.84 | |||
Earnings Per Share Growth | -40.48% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.81 | |||
Price/Book (Q) | 1.47 | |||
Enterprise Value/Revenue (TTM) | 1.22 | |||
Price | $11.53 | |||
Enterprise Value/EBITDA (TTM) | 9.05 | |||
Enterprise Value/EBIT | 14.09 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 330.33M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | $0.42 | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | 56.57% | |||
Dividend Per Share (Most Recent) | $0.42 | |||
Company Info | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | -- | |||
Website | www.clariant.com | |||
Country | Switzerland | |||
Year Founded | 1886 | |||
Profitability | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 8.68% | |||
Profit Margin | 5.85% | |||
Management Effectiveness | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 3.86% | |||
Return on Equity | 11.85% | |||
Income Statement | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 4.72B | |||
Total Revenue (TTM) | 4.72B | |||
Revenue Per Share | $14.28 | |||
Gross Profit (TTM) | 1.39B | |||
EBITDA (TTM) | 638.04M | |||
EBIT (TTM) | 409.60M | |||
Net Income (TTM) | 276.42M | |||
Net Income Avl. to Common (TTM) | 276.42M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -- | |||
EPS Diluted (TTM) | 0.84 | |||
EPS Diluted Growth (Q YOY) | -58.11% | |||
Balance Sheet | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 435.90M | |||
Cash Per Share (Q) | $1.32 | |||
Total Current Assets (Q) | 2.35B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.77B | |||
Current Ratio (Q) | 1.467 | |||
Book Value Per Share (Q) | $7.85 | |||
Total Assets (Q) | 6.91B | |||
Total Current Liabilities (Q) | 1.60B | |||
Total Debt (Q) | 2.08B | |||
Total Liabilities (Q) | 4.14B | |||
Total Common Equity (Q) | 2.58B | |||
Cash Flow | CLZNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -906.13M | |||
Cash from Financing (TTM) | 305.77M | |||
Net Change in Cash (TTM) | -112.05M | |||
Levered Free Cash Flow (TTM) | 111.57M | |||
Cash from Operations (TTM) | 477.09M | |||